Cell therapy for the treatment of heart disease: Renovation work on the broken heart is still in progress. (2021)
Attributed to:
Manufacture scale up of human pericyte progenitor cells for regenerative medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.freeradbiomed.2020.12.444
PubMed Identifier: 33421587
Publication URI: http://europepmc.org/abstract/MED/33421587
Type: Journal Article/Review
Volume: 164
Parent Publication: Free radical biology & medicine
ISSN: 0891-5849